{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:39:18Z","timestamp":1787236758811,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00467-008-1011-y","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T08:06:26Z","timestamp":1223280386000},"page":"613-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates"],"prefix":"10.1007","volume":"24","author":[{"given":"Ari","family":"Auron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyat","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri S.","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"key":"1011_CR1","first-page":"251","volume-title":"Renal and electrolyte disorders","author":"MM Popovtzer","year":"1986","unstructured":"Popovtzer MM, Knochel J (1986) Disorders of calcium, phosphorus, vitamin D and parathyroid hormone activity. In: Schrier RW (ed) Renal and electrolyte disorders, 3rd edn. Little, Brown, Boston, pp 251\u2013329","edition":"3"},{"key":"1011_CR2","first-page":"489","volume-title":"Disorders of bone and mineral metabolism","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Mulder JE, Silverberg SJ (2002) Hypercalcemic states: differential diagnosis and acute management. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 489\u2013515","edition":"2"},{"key":"1011_CR3","first-page":"37","volume-title":"Clinical pediatric nephrology","author":"FN Ali","year":"2007","unstructured":"Ali FN, Langman CB (2007) Disorders of mineral metabolism. In: Kher KK, Schnaper HW, Makker SP (eds) Clinical pediatric nephrology, 2nd edn. Informa, London, pp 37\u201360","edition":"2"},{"key":"1011_CR4","first-page":"207","volume-title":"Comprehensive clinical nephrology","author":"A Jefferson","year":"2003","unstructured":"Jefferson A, Zager R (2003) Causes of acute renal failure. In: Johnson RJ, Feehally J (eds) Comprehensive clinical nephrology, 2nd edn. Mosby, Edinburgh, pp 207\u2013224","edition":"2"},{"key":"1011_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352:373\u2013379","journal-title":"N Engl J Med"},{"key":"1011_CR6","first-page":"289","volume":"65","author":"N Alos","year":"2006","unstructured":"Alos N, Eug\u00e8ne D, Fillion M, Powell J, Kokta V, Chabot G (2006) Pamidronate: treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res 65:289\u2013294","journal-title":"Horm Res"},{"key":"1011_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/01.PCC.0000059423.62268.02","volume":"4","author":"M Mathur","year":"2003","unstructured":"Mathur M, Sykes JA, Saxena VR, Rao SP, Goldman GM (2003) Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Pediatr Crit Care Med 4:252\u2013255","journal-title":"Pediatr Crit Care Med"},{"key":"1011_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s004670050546","volume":"12","author":"E Sellers","year":"1998","unstructured":"Sellers E, Sharma A, Rodd C (1998) The use of pamidronate in three children with renal disease. Pediatr Nephrol 12:778\u2013781","journal-title":"Pediatr Nephrol"},{"key":"1011_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1515\/JPEM.2007.20.11.1241","volume":"20","author":"M Chatterjee","year":"2007","unstructured":"Chatterjee M, Speiser PW (2007) Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. J Pediatr Endocrinol Metab 20:1241\u20131248","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1011_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.mph.0000151932.47598.00","volume":"27","author":"C Kerdudo","year":"2005","unstructured":"Kerdudo C, Aerts I, Fattet S, Chevret L, Pacquement H, Doz F, Michon J, Garabedian M, Orbach D (2005) Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol 27:23\u201327","journal-title":"J Pediatr Hematol Oncol"},{"key":"1011_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/(SICI)1096-911X(199807)31:1<39::AID-MPO10>3.0.CO;2-Y","volume":"31","author":"T Kutluk","year":"1998","unstructured":"Kutluk T, Aky\u00fcz C, Yal\u00e7in B, Varan A, B\u00fcy\u00fckpamuk\u00fc\u00e7u M (1998) Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Oncol 31:39","journal-title":"Med Pediatr Oncol"},{"key":"1011_CR12","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra022308","volume":"349","author":"JT Chang","year":"2003","unstructured":"Chang JT, Green L, Beitz J (2003) Renal failure with the use of zoledronic acid. N Engl J Med 349:1676\u20131679; discussion 1676\u20131679","journal-title":"N Engl J Med"},{"key":"1011_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/annonc\/mdj105","volume":"17","author":"T Tanvetyanon","year":"2006","unstructured":"Tanvetyanon T, Stiff PJ (2006) Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 17:897\u2013907","journal-title":"Ann Oncol"},{"issue":"Suppl 3","key":"1011_CR14","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1177\/089686080102103S45","volume":"3","author":"C Rodd","year":"2001","unstructured":"Rodd C (2001) Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues. Perit Dial Int 21(Suppl 3):S256\u2013S260","journal-title":"Perit Dial Int 21 Suppl"},{"key":"1011_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, Park J, Nasr SH, Hoh S, Siegel DS, D\u2019Agati VD (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281\u2013289","journal-title":"Kidney Int"},{"key":"1011_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00000441-200401000-00004","volume":"327","author":"JW Caldwell","year":"2004","unstructured":"Caldwell JW, Arsura EL, Kilgore WB, Reddy CM, Johnson RH (2004) Hypercalcemia in patients with disseminated coccidioidomycosis. Am J Med Sci 327:15\u201318","journal-title":"Am J Med Sci"},{"key":"1011_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.semnephrol.2008.03.007","volume":"28","author":"G Procino","year":"2008","unstructured":"Procino G, Mastrofrancesco L, Mira A, Tamma G, Carmosino M, Emma F, Svelto M, Valenti G (2008) Aquaporin 2 and apical calcium-sensing receptor: new players in polyuric disorders associated with hypercalciuria. Semin Nephrol 28:297\u2013305","journal-title":"Semin Nephrol"},{"key":"1011_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0006-291X(02)02133-2","volume":"297","author":"S McLarnon","year":"2002","unstructured":"McLarnon S, Holden D, Ward D, Jones M, Elliott A, Riccardi D (2002) Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun 297:71\u201377","journal-title":"Biochem Biophys Res Commun"},{"key":"1011_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ncpneph0248","volume":"2","author":"H Trimarchi","year":"2006","unstructured":"Trimarchi H, Lombi F, Forrester M, Elizondo C, Sawinski D, Pereyra H, Freixas E (2006) Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Nat Clin Pract Nephrol 2:459\u2013463","journal-title":"Nat Clin Pract Nephrol"},{"key":"1011_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00431-003-1298-4","volume":"162","author":"T Srivastava","year":"2003","unstructured":"Srivastava T, Alon US (2003) The role of bisphosphonates in diseases of childhood. Eur J Pediatr 162:735\u2013751","journal-title":"Eur J Pediatr"},{"key":"1011_CR21","first-page":"138","volume":"43","author":"F Tamion","year":"1995","unstructured":"Tamion F, Bonmarchand F, Girault C, Chevron V, Leroy J (1995) Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia. Clin Nephrol 43:138\u2013139","journal-title":"Clin Nephrol"},{"key":"1011_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2265.1995.tb02916.x","volume":"43","author":"PL Selby","year":"1995","unstructured":"Selby PL, Davies M, Marks JS, Mawer EB (1995) Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) 43:531\u2013536","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1011_CR23","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1016\/S0272-6386(03)00214-2","volume":"41","author":"D Banerjee","year":"2003","unstructured":"Banerjee D, Asif A, Striker L, Preston RA, Bourgoignie JJ, Roth D (2003) Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity. Am J Kidney Dis 41:E18","journal-title":"Am J Kidney Dis"},{"key":"1011_CR24","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1093\/ndt\/gfh504","volume":"19","author":"S Lee","year":"2004","unstructured":"Lee S, Glicklich D, Coco M (2004) Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction. Nephrol Dial Transplant 19:2870\u20132873","journal-title":"Nephrol Dial Transplant"},{"key":"1011_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1939-1676.2005.tb02654.x","volume":"19","author":"RA Hostutler","year":"2005","unstructured":"Hostutler RA, Chew DJ, Jaeger JQ, Klein S, Henderson D, DiBartola SP (2005) Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia. J Vet Intern Med 19:29\u201333","journal-title":"J Vet Intern Med"},{"key":"1011_CR26","first-page":"225","volume":"34","author":"AS Yap","year":"1990","unstructured":"Yap AS, Hockings GI, Fleming SJ, Khafagi FA (1990) Use of aminohydroxypropylidene bisphosphonate (AHPrBP, \u201cAPD\u201d) for the treatment of hypercalcemia in patients with renal impairment. Clin Nephrol 34:225\u2013229","journal-title":"Clin Nephrol"},{"key":"1011_CR27","first-page":"175","volume":"45","author":"CE Machado","year":"1996","unstructured":"Machado CE, Flombaum CD (1996) Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol 45:175\u2013179","journal-title":"Clin Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-1011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-008-1011-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-1011-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-1011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T13:08:16Z","timestamp":1610802496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-008-1011-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1007\/s00467-008-1011-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"24 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}